Imatinib plasma levels: correlation with clinical benefit in GIST patients

Detalles Bibliográficos
Autores principales: Widmer, N, Decosterd, L A, Csajka, C, Montemurro, M, Haouala, A, Leyvraz, S, Buclin, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853086/
https://www.ncbi.nlm.nih.gov/pubmed/20179709
http://dx.doi.org/10.1038/sj.bjc.6605584
_version_ 1782180004783718400
author Widmer, N
Decosterd, L A
Csajka, C
Montemurro, M
Haouala, A
Leyvraz, S
Buclin, T
author_facet Widmer, N
Decosterd, L A
Csajka, C
Montemurro, M
Haouala, A
Leyvraz, S
Buclin, T
author_sort Widmer, N
collection PubMed
description
format Text
id pubmed-2853086
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-28530862011-03-30 Imatinib plasma levels: correlation with clinical benefit in GIST patients Widmer, N Decosterd, L A Csajka, C Montemurro, M Haouala, A Leyvraz, S Buclin, T Br J Cancer Letter to the Editor Nature Publishing Group 2010-03-30 2010-02-23 /pmc/articles/PMC2853086/ /pubmed/20179709 http://dx.doi.org/10.1038/sj.bjc.6605584 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Widmer, N
Decosterd, L A
Csajka, C
Montemurro, M
Haouala, A
Leyvraz, S
Buclin, T
Imatinib plasma levels: correlation with clinical benefit in GIST patients
title Imatinib plasma levels: correlation with clinical benefit in GIST patients
title_full Imatinib plasma levels: correlation with clinical benefit in GIST patients
title_fullStr Imatinib plasma levels: correlation with clinical benefit in GIST patients
title_full_unstemmed Imatinib plasma levels: correlation with clinical benefit in GIST patients
title_short Imatinib plasma levels: correlation with clinical benefit in GIST patients
title_sort imatinib plasma levels: correlation with clinical benefit in gist patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853086/
https://www.ncbi.nlm.nih.gov/pubmed/20179709
http://dx.doi.org/10.1038/sj.bjc.6605584
work_keys_str_mv AT widmern imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients
AT decosterdla imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients
AT csajkac imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients
AT montemurrom imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients
AT haoualaa imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients
AT leyvrazs imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients
AT buclint imatinibplasmalevelscorrelationwithclinicalbenefitingistpatients

Ejemplares similares